Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis

被引:0
|
作者
S Bayraktar
O Kasapcopur
N Arisoy
B Batar
M Guven
机构
[1] Istanbul University,
[2] Cerrahpasa Medical School,undefined
关键词
Allele Frequency; Length Polymorphism; Restriction Fragment Length Polymorphism; Restriction Fragment; Fragment Length Polymorphism;
D O I
10.1186/1546-0096-6-S1-P6
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Tumor necrosis factor-alpha gene polymorphism in Turkish patients with psoriasis
    Yeniay, Yildiray
    Koc, Erol
    Akar, Hatice
    META GENE, 2021, 28
  • [22] A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors
    Heather M. Walters
    Nancy Pan
    Thomas J. A. Lehman
    Alexa Adams
    Wei-Ti Huang
    Lemonia Sitaras
    Susanna Cunningham-Rundles
    Thomas J. Walsh
    Sima S. Toussi
    Clinical Rheumatology, 2015, 34 : 457 - 464
  • [23] A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors
    Walters, Heather M.
    Pan, Nancy
    Lehman, Thomas J. A.
    Adams, Alexa
    Huang, Wei-Ti
    Sitaras, Lemonia
    Cunningham-Rundles, Susanna
    Walsh, Thomas J.
    Toussi, Sima S.
    CLINICAL RHEUMATOLOGY, 2015, 34 (03) : 457 - 464
  • [24] New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis
    Breedveld, F
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 233 - 238
  • [25] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [26] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [27] Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies
    Joerg-Patrick Stübgen
    Journal of Neurology, 2011, 258 : 961 - 970
  • [28] Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies
    Stuebgen, Joerg-Patrick
    JOURNAL OF NEUROLOGY, 2011, 258 (06) : 961 - 970
  • [29] Psoriasis Associated with Anti-Tumor Necrosis Factor-Alpha Therapies in Children with Inflammatory Bowel Disease, Juvenile Idiopathic Arthritis, and Chronic Noninfectious Osteomyelitis
    Buckley, Lisa
    Xiao, Rui
    Perman, Marissa
    Grossman, Andrew
    Weiss, Pamela F.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] Association between interleukin-1, interleukin-6, and tumor necrosis factor-alpha polymorphisms and juvenile idiopathic arthritis: a meta-analysis
    Jung, Jae Hyun
    Seok, Hongdeok
    Bang, Cho Hee
    Kim, Cholhee
    Song, Gwan Gyo
    Choi, Sung Jae
    MINERVA PEDIATRICS, 2022, 74 (02): : 213 - 221